Christopher S. Freet

516 total citations
23 papers, 391 citations indexed

About

Christopher S. Freet is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Christopher S. Freet has authored 23 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 6 papers in Cognitive Neuroscience. Recurrent topics in Christopher S. Freet's work include Neurotransmitter Receptor Influence on Behavior (11 papers), Neuroscience and Neuropharmacology Research (5 papers) and Receptor Mechanisms and Signaling (5 papers). Christopher S. Freet is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (11 papers), Neuroscience and Neuropharmacology Research (5 papers) and Receptor Mechanisms and Signaling (5 papers). Christopher S. Freet collaborates with scholars based in United States and India. Christopher S. Freet's co-authors include Patricia S. Grigson, Xiaorui Tang, Robert C. Twining, Ellen J. Hess, Kiyoshi Egami, Scott C. Bunce, A. Hajnal, Ann M. Rogers, Cathy Steffen and Eric J. Nestler and has published in prestigious journals such as Scientific Reports, Physiology & Behavior and Behavioral Neuroscience.

In The Last Decade

Christopher S. Freet

22 papers receiving 387 citations

Peers

Countries citing papers authored by Christopher S. Freet

Since Specialization

Citations

This map shows the geographic impact of Christopher S. Freet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher S. Freet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher S. Freet more than expected).

Fields of papers citing papers by Christopher S. Freet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher S. Freet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher S. Freet. The network helps show where Christopher S. Freet may publish in the future.

Co-authorship network of co-authors of Christopher S. Freet

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher S. Freet. A scholar is included among the top collaborators of Christopher S. Freet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher S. Freet. Christopher S. Freet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocol 2025 ·Addiction Science & Clinical Practice ·Christopher S. Freet, Kirsten Shuler, (unknown), Eric Weintraub, Aaron D. Greenblatt, (unknown), Edward V. Nunes, Katrina L. Foster, Lan Kong, Nazia Raja‐Khan, H. Harrington Cleveland, Patricia S. Grigson, Scott C. Bunce, Timothy R. Brick, Jennifer E. Nyland	0
2	Contemporaneous Link Between Pain and Craving in Patients Recovering from Prescription Opioid Use Disorder During Residential Treatment 2025 ·Substance Use & Misuse ·(unknown), (unknown), Christopher S. Freet, Erin Deneke, (unknown), Timothy R. Brick, H. Harrington Cleveland, Scott C. Bunce	1
3	Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder 2024 ·Addiction Science & Clinical Practice ·Christopher S. Freet, (unknown), Timothy R. Brick, Erin Deneke, Emily Wasserman, (unknown), (unknown), Lan Kong, Nazia Raja‐Khan, Jennifer E. Nyland, Amy C. Arnold, Venkatesh Basappa Krishnamurthy, Julio Fernández‐Mendoza, H. Harrington Cleveland, (unknown), (unknown), (unknown), Hasan Ayaz, Patricia S. Grigson, Scott C. Bunce	5
4	Prefrontal cortical response to natural rewards and self-reported anhedonia are associated with greater craving among recently withdrawn patients in residential treatment for opioid use disorder 2022 ·Brain Research Bulletin ·(unknown), (unknown), Christopher S. Freet, Erin Deneke, Timothy R. Brick, H. Harrington Cleveland, Scott C. Bunce	5
5	Dose titration with the glucagon-like peptide-1 agonist, liraglutide, reduces cue- and drug-induced heroin seeking in high drug-taking rats 2022 ·Brain Research Bulletin ·(unknown), (unknown), Nikhil Acharya, Jennifer E. Nyland, Amy C. Arnold, Christopher S. Freet, Scott C. Bunce, Patricia S. Grigson	13
6	Reregulation of cortisol levels and sleep in patients with prescription opioid use disorder during long-term residential treatment 2021 ·Drug and Alcohol Dependence ·Dahlia Mukherjee, (unknown), (unknown), Andrew S. Huhn, Edward O. Bixler, Lan Kong, Roger E. Meyer, Erin Deneke, Christopher S. Freet, Scott C. Bunce	9
7	The Human Transient Receptor Potential Melastatin 2 Ion Channel Modulates ROS Through Nrf2 2019 ·Scientific Reports ·Lei Bao, Fernanda Festa, Christopher S. Freet, (unknown), Iwona Hirschler‐Laszkiewicz, Shu-Jen Chen, Kerry Keefer, Hong‐Gang Wang, Andrew D. Patterson, Joseph Y. Cheung, Barbara A. Miller	24
8	The role of dose and restriction state on morphine-, cocaine-, and LiCl-induced suppression of saccharin intake: A comprehensive analysis 2016 ·Physiology & Behavior ·Robert C. Twining, Christopher S. Freet, Robert Wheeler, Christian Reich, (unknown), (unknown), Patricia S. Grigson	4
9	Increased intravenous morphine self-administration following Roux-en-Y gastric bypass in dietary obese rats 2015 ·Brain Research Bulletin ·(unknown), Christopher S. Freet, (unknown), Ann M. Rogers, A. Hajnal	15
10	Ceftriaxone attenuates acquisition and facilitates extinction of cocaine-induced suppression of saccharin intake in C57BL/6J mice 2015 ·Physiology & Behavior ·Christopher S. Freet, (unknown)	5
11	Cocaine-induced suppression of saccharin intake and morphine modulation of Ca2+ channel currents in sensory neurons of OPRM1 A118G mice 2014 ·Physiology & Behavior ·Christopher S. Freet, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Víctor Ruiz-Velasco, Patricia S. Grigson	7
12	Baroreflex and chemoreflex controls of sympathetic activity following intermittent hypoxia 2013 ·Autonomic Neuroscience ·Christopher S. Freet, (unknown), Xiaorui Tang	54
13	Compared with DBA/2J mice, C57BL/6J mice demonstrate greater preference for saccharin and less avoidance of a cocaine-paired saccharin cue. 2013 ·Behavioral Neuroscience ·Christopher S. Freet, (unknown), Patricia S. Grigson	11
14	Fischer rats are more sensitive than Lewis rats to the suppressive effects of morphine and the aversive kappa-opioid agonist spiradoline. 2013 ·Behavioral Neuroscience ·Christopher S. Freet, Robert Wheeler, (unknown), Nicole A. S. Mosblech, Patricia S. Grigson	9
15	Pontine and thalamic influences on fluid rewards: I. Operant responding for sucrose and corn oil 2011 ·Physiology & Behavior ·Nu‐Chu Liang, Christopher S. Freet, Patricia S. Grigson, Ralph Norgren	8
16	Overexpression of ΔFosB is associated with attenuated cocaine-induced suppression of saccharin intake in mice. 2009 ·Behavioral Neuroscience ·Christopher S. Freet, Cathy Steffen, Eric J. Nestler, Patricia S. Grigson	10
17	Abnormal latent inhibition and impulsivity in coloboma mice, a model of ADHD 2006 ·Neurobiology of Disease ·(unknown), Christopher S. Freet, Robert C. Twining, Kiyoshi Egami, Patricia S. Grigson, Ellen J. Hess	59
18	Lewis rats are more sensitive than Fischer rats to successive negative contrast, but less sensitive to the anxiolytic and appetite-stimulating effects of chlordiazepoxide 2006 ·Pharmacology Biochemistry and Behavior ·Christopher S. Freet, (unknown), (unknown), Katherine Riegel, Patricia S. Grigson	16
19	The suppressive effects of sucrose and cocaine, but not lithium chloride, are greater in Lewis than in Fischer rats: Evidence for the reward comparison hypothesis. 2000 ·Behavioral Neuroscience ·Patricia S. Grigson, Christopher S. Freet	72
20	The suppressive effects of sucrose and cocaine, but not lithium chloride, are greater in Lewis than in Fischer rats: Evidence for the reward comparison hypothesis. 2000 ·Behavioral Neuroscience ·Patricia S. Grigson, Christopher S. Freet	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact